LuerMSRhoneyDH. Tiagabine: A novel antiepileptic drug. Ann Pharmacother1998;32:1173–80.
2.
MattsonRHCramerJACollinsJF. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Neurology1996;47:68–76.
3.
MattsonRHCramerJACollinsJF, Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of partial seizures and secondarily generalized tonic—clonic seizures in adults. N Engl J Med1992;327:765–71.
4.
MattsonRHCramerJACollinsJF. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized seizures. N Engl J Med1985;313:145–51.
5.
MarsonAGKadirZAChadwickDW. New antiepileptic drugs: A systematic review of their efficacy and tolerability. BMJ1996;313:1169–74.
6.
MotteJTrevathanEArvidssonJFVBarreraMNMullensELManascoP. Lamotrigine for generalized seizures associated with the Lennox—Gastaut syndrome. N Engl J Med1997;337:1807–12.
7.
Report of the ILAE Commission on Antiepileptic Drugs. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia1998;39:799–803.
8.
GilmanJTDuchownyMJayakarPResnickTJ. Medical intractability in children evaluated for epilepsy surgery. Neurology1994;44:1341–3.
9.
BerkovicSF. Aggravation of generalized epilepsies. Epilepsia1998;39 (suppl 3):11–4.
10.
MacdonaldRL. Is there a mechanistic basis for rational polypharmacy?Epilepsy Res1996;11(suppl 11):79–93.
11.
1997 Drug topics red book. Montvale, NJ: Medical Economics, 1997.
